Febrile Neutropenia

Oct 16, 2016 by in ONCOLOGY Comments Off on Febrile Neutropenia

Clinical scenario Recommendation Level of evidencea Risk stratification Must be individualized at local institutions due to lack of evidence to support the needs of each individual treatment area 2C Baseline…

read more

Knowledge Gaps and Opportunities for Research

Oct 16, 2016 by in ONCOLOGY Comments Off on Knowledge Gaps and Opportunities for Research

© Springer Berlin Heidelberg 2015James H. Feusner, Caroline A. Hastings and Anurag K. Agrawal (eds.)Supportive Care in Pediatric OncologyPediatric Oncology10.1007/978-3-662-44317-0_18 18. Knowledge Gaps and Opportunities for Research Anurag K. Agrawal1  , Caroline A. Hastings1 and James H. Feusner1 (1) Department of Hematology/Oncology, Children’s…

read more

Immunization Practice in Pediatric Oncology

Oct 16, 2016 by in ONCOLOGY Comments Off on Immunization Practice in Pediatric Oncology

  Prior to chemotherapyb During chemotherapyc After chemotherapy completionc, d Diphtheria-tetanus-acellular pertussis  Continuation of primary series during lower-intensity phases of therapy (i.e., ALL in maintenance) Continuation of primary series; booster…

read more

Hematopoietic Growth Factors

Oct 16, 2016 by in ONCOLOGY Comments Off on Hematopoietic Growth Factors

Clinical scenario Recommendation Level of evidenceb Treatment of myelosuppression after chemotherapy (primary prophylaxis) Consider if risk of neutropenia is ≥20 % or if patient had neutropenia with previous course of…

read more

Prevention of Infection

Oct 16, 2016 by in ONCOLOGY Comments Off on Prevention of Infection

Recommendation Grade Comments Reference Data from studies of non-oncology patientsa Data from studies of adult oncology patientsa Data from studies of pediatric oncology patientsa Antibacterial prophylaxis with a fluoroquinolone should…

read more

Cardiopulmonary Emergencies

Oct 16, 2016 by in ONCOLOGY Comments Off on Cardiopulmonary Emergencies

Clinical scenario Recommendations Level of evidencea SVCS/SMS Elevate head of the bed 1C Place all IV lines in lower extremities 2C Consider use of loop diuretics 2C Remove indwelling catheter…

read more

The Acute Abdomen

Oct 16, 2016 by in ONCOLOGY Comments Off on The Acute Abdomen

Treatment modality Potential side effects Chemotherapy Bacterial overgrowth Bile acid malabsorption Pancreatic insufficiency Neutropenic enterocolitis Edema, ulceration, atrophy Increased bowel permeability Transmural infection Radiation therapy Radiation enteritis Stricture Inflammation/cell death…

read more

Nutrition

Oct 16, 2016 by in ONCOLOGY Comments Off on Nutrition

Malnutrition or evidence of cachexia present at diagnosis Highly emetogenic chemotherapeutic regimens Treatment regimens associated with severe GI complications such as constipation, diarrhea, loss of appetite, mucositis, enterocolitis (i.e., treatment…

read more

Management of Acute Radiation Side Effects

Oct 16, 2016 by in ONCOLOGY Comments Off on Management of Acute Radiation Side Effects

Organ RT side effect Treatment Level of evidenceb Hematologic Neutropenia Consider G-CSF (see Chap.​ 15 for more detail) 1C Thrombocytopenia Platelet transfusion 1C Anemia Red blood cell transfusion; erythropoietin (EPO)-stimulating…

read more

Nausea and Vomiting

Oct 16, 2016 by in ONCOLOGY Comments Off on Nausea and Vomiting

High risk (>90 % frequency of emesis in the absence of prophylaxis) Altretamine bCytarabine 3 g/m2/dose Procarbazine (oral) bCarboplatin Dacarbazine Streptozocin Carmustine >250 mg/m2 bDactinomycin bThiotepa ≥300 mg/m2 bCisplatin Mechlorethamine bCyclophosphamide…

read more
Get Clinical Tree app for offline access